Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine

N Engl J Med. 2021 Apr 15;384(15):1468-1470. doi: 10.1056/NEJMc2102179. Epub 2021 Mar 17.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Letter

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • Antibodies, Neutralizing / blood*
  • Antibodies, Viral / blood
  • COVID-19 / immunology*
  • COVID-19 / prevention & control
  • COVID-19 Vaccines / immunology*
  • Humans
  • Mutation
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology*
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / immunology
  • Statistics, Nonparametric
  • Vaccines, Synthetic / immunology
  • mRNA Vaccines

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • Vaccines, Synthetic
  • spike protein, SARS-CoV-2
  • 2019-nCoV Vaccine mRNA-1273